首页> 外文期刊>Case Reports in Nephrology >Focal Segmental Glomerulosclerosis and Scheduled Pretransplant Plasmapheresis: A Timely Diagnosis of Nail-Patella Syndrome Avoided More Futile Immunosuppression
【24h】

Focal Segmental Glomerulosclerosis and Scheduled Pretransplant Plasmapheresis: A Timely Diagnosis of Nail-Patella Syndrome Avoided More Futile Immunosuppression

机译:局灶性节段性肾小球粥样硬化和预定的预体浆术:及时诊断钉髌骨综合征避免了更徒劳的免疫抑制

获取原文
           

摘要

Focal and segmental glomerulosclerosis (FSGS) is a histopathological pattern of injury. As such, it encompasses a wide variety of dissimilar entities with different pathophysiologic mechanisms. Although ultrastructural morphological characteristics can specifically diagnose certain diseases and genetic mutations can also be unravelled, this ideal situation is generally not available worldwide. In this respect, when proteinuria with or without nephrotic syndrome is encountered and FSGS is the histological lesion, patients start to be prescribed different regimes of immunosuppression, which should only be indicated in cases of primary FSGS, a rare entity that is elusive to response and can hardly be precisely diagnosed. We present a 35-year-old female patient with a life-long diagnosis of FSGS and a heavy burden of immunosuppressants, which had been unable to manage the persistent proteinuria that eventually led to end-stage kidney disease. She was referred to us to organize the kidney transplant. Plasmapheresis had been previously suggested to her to prevent the relapse of primary FSGS. A genetic test disclosed that the patient was heterozygous for LMX1B, and the diagnosis of nail-patella syndrome was made. In this entity, immunosuppression is not indicated, and there is no recurrence of the disease in the transplanted allograft.
机译:局灶性和节段性肾小球粥样硬化(FSG)是损伤的组织病理学模式。因此,它包括具有不同病理生理机制的各种不同的实体。虽然超微结构形态特征可以专门诊断某些疾病和遗传突变也可以解开,但这种理想情况一般都在全球范围内。在这方面,当遇到或没有肾病综合征的蛋白尿和组织学病变时,患者开始被规定的免疫抑制制度,这只应该在初级FSG的情况下表明,这是一种难以捉摸的实体,难以应对几乎无法精确诊断出来。我们展示了一名35岁的女性患者,具有终身诊断的FSG和免疫抑制剂的沉重负担,这一直无法管理最终导致末期肾病的持续蛋白尿。她被提到我们组织肾移植。先前已经提出了血浆丸剂以防止初级FSG的复发。遗传测试公开了患者对LMX1B的杂合,并制备了甲髌骨综合征的诊断。在该实体中,未指出免疫抑制,移植的同种异体移植物中没有疾病的复发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号